Working across boundaries between the laboratory and clinic, program members are committed to bringing the latest medical breakthroughs to patients through a range of innovative Phase II and Phase III clinical trials. Approaches under study include monoclonal antibodies and genetically engineered vaccines developed from a patient's own cancer cells.

To see a list of active clinical trials, please visit the Find a Clinical Trial page.

Richard Hoppe, MD

Sandra Horning, MD

Saul Rosenberg, MD